Figure 3. Clodronate-induced chimerism is durable in immune organs.
The immune organs indicated to the left of each row were removed on day 225 post BM transplantation of the groups indicated at the bottom of each column, corresponding to the mice analyzed in Fig. 2, and hematopoietic chimerism was assessed by flow cytometry. The data shown are from one mouse from each of the treatment groups defined at the bottom of each column of plots and are representative of a total of 5 (control liposomes), 10 (clodronate) and 5 (50 million cells, no clodronate) mice analyzed from each group combined from 2 independent experiments performed.